抗内毒素预防心脏直视手术后发热及革兰氏阴性菌感染
Prevention of fever and gram negative infection after open heart surgery by antiendotoxin.
作者信息
Freeman R, Gould F K
出版信息
Thorax. 1985 Nov;40(11):846-8. doi: 10.1136/thx.40.11.846.
Abstract
Naturally occurring preoperative antibody to enteric Gram negative bacilli (Escherichia coli agglutinins or antiendotoxin, or both) in 30 patients who had had open heart surgery was associated with a significantly lower incidence of early postoperative fever and postoperative Gram negative infection than occurred in 56 patients without preoperative antibodies. The protective effect was shown to be associated with antiendotoxin rather than antibody to the somatic antigen of the bacteria. Active or passive immunisation of patients having open heart surgery against endotoxin is likely to decrease significantly the morbidity after cardiopulmonary bypass.
摘要
30例接受心脏直视手术患者体内天然存在的针对肠道革兰氏阴性杆菌的术前抗体（大肠杆菌凝集素或抗内毒素，或两者皆有），与56例无术前抗体患者相比，术后早期发热和术后革兰氏阴性感染的发生率显著降低。研究表明，这种保护作用与抗内毒素有关，而非与细菌菌体抗原的抗体有关。对接受心脏直视手术的患者进行主动或被动抗内毒素免疫，可能会显著降低体外循环后的发病率。
相似文献
1
Prevention of fever and gram negative infection after open heart surgery by antiendotoxin.抗内毒素预防心脏直视手术后发热及革兰氏阴性菌感染
Thorax. 1985 Nov;40(11):846-8. doi: 10.1136/thx.40.11.846.
2
Rises in antibody to enteric gram negative bacilli after open heart surgery: a possible mechanism for postoperative pyrexia.心脏直视手术后抗肠道革兰氏阴性杆菌抗体升高：术后发热的一种可能机制。
Thorax. 1985 Jul;40(7):538-41. doi: 10.1136/thx.40.7.538.
3
Antibody to endotoxin is associated with decreased frequency of postoperative infection.抗内毒素抗体与术后感染发生率降低有关。
Am J Obstet Gynecol. 1989 Feb;160(2):317-9. doi: 10.1016/0002-9378(89)90433-x.
4
[Prevention and treatment of infections in open heart surgery (author's transl)].心脏直视手术中感染的预防与治疗（作者译）
Ateneo Parmense Acta Biomed. 1976 Sep-Oct;47(5):561-72.
5
6
Update on antiendotoxin therapies.抗内毒素疗法的最新进展。
Hosp Med. 2000 Apr;61(4):254-8. doi: 10.12968/hosp.2000.61.4.1874.
7
[Prophylactic use of cefpiramide (CPM) in open heart surgery].头孢匹胺（CPM）在心脏直视手术中的预防性应用
Kyobu Geka. 1989 Nov;42(12):991-4.
8
Positive cultures from cardiopulmonary bypass: prevalence and relevance regarding postoperative infection.体外循环中的阳性培养物：术后感染的患病率和相关性。
Eur J Cardiothorac Surg. 2011 Aug;40(2):372-8. doi: 10.1016/j.ejcts.2010.11.063. Epub 2011 Jan 17.
9
Antimicrobial prophylaxis in cardiovascular surgery.心血管手术中的抗菌预防
Scand J Infect Dis Suppl. 1990;70:80-6.
10
Antiendotoxin antibody levels in unstable angina: lessons from chronic heart failure and cardiopulmonary bypass.不稳定型心绞痛中的抗内毒素抗体水平：来自慢性心力衰竭和体外循环的经验教训。
Am J Cardiol. 2001 Nov 15;88(10):1217. doi: 10.1016/s0002-9149(01)01960-9.
引用本文的文献
1
Searching for the etiology of systemic inflammatory response syndrome: is SIRS occult endotoxemia?
Intensive Care Med. 2006 Feb;32(2):181-184. doi: 10.1007/s00134-005-0067-4. Epub 2006 Feb 1.
2
Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine.新型脂质体完全核心脂多糖疫苗的制备及临床前评估
Infect Immun. 2000 Nov;68(11):6202-8. doi: 10.1128/IAI.68.11.6202-6208.2000.
3
All accessible epitopes in the Salmonella lipopolysaccharide core are associated with branch residues.沙门氏菌脂多糖核心中所有可及的表位都与分支残基相关。
Infect Immun. 1999 Feb;67(2):998-1003. doi: 10.1128/IAI.67.2.998-1003.1999.
4
Sequential anti-core glycolipid immunoglobulin antibody activities in patients with and without septic shock and their relation to outcome.伴有和不伴有感染性休克患者的抗核心糖脂免疫球蛋白抗体活性序列及其与预后的关系。
Ann Surg. 1993 Mar;217(3):300-6. doi: 10.1097/00000658-199303000-00013.
5
Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies.通过酶联免疫吸附测定人免疫球蛋白G抗内毒素抗体揭示大肠杆菌与沙门氏菌光滑型和粗糙型突变体脂多糖之间的血清学关系。
Infect Immun. 1987 Nov;55(11):2706-14. doi: 10.1128/iai.55.11.2706-2714.1987.
6
Serum immunoglobulins to endotoxin core glycolipid: acute leukaemia and other cancers.针对内毒素核心糖脂的血清免疫球蛋白：急性白血病及其他癌症
Arch Dis Child. 1990 Jul;65(7):771-3. doi: 10.1136/adc.65.7.771.
本文引用的文献
1
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.用人抗突变型大肠杆菌抗血清治疗革兰氏阴性菌血症和休克。
N Engl J Med. 1982 Nov 11;307(20):1225-30. doi: 10.1056/NEJM198211113072001.
2
Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin.抗脂多糖免疫疗法在妇产科源性感染性休克治疗中的应用
Lancet. 1984 May 5;1(8384):981-3. doi: 10.1016/s0140-6736(84)92324-9.
3
Host-parasite interaction in patients with infections due to Escherichia coli. II. Serologic response of the host.
J Lab Clin Med. 1965 Oct;66(4):613-26.
4
Treatment and prevention of intravascular coagulation with antiserum to endotoxin.用抗内毒素抗血清治疗和预防血管内凝血
J Infect Dis. 1973 Jul;128:Suppl:157-64. doi: 10.1093/infdis/128.supplement_1.s157.
5
Pyrexia following open heart surgery. The role of bacterial infection.心脏直视手术后的发热。细菌感染的作用。
Anaesthesia. 1974 Sep;29(5):529-36. doi: 10.1111/j.1365-2044.1974.tb00715.x.
6
Rises in antibody to enteric gram negative bacilli after open heart surgery: a possible mechanism for postoperative pyrexia.心脏直视手术后抗肠道革兰氏阴性杆菌抗体升高：术后发热的一种可能机制。
Thorax. 1985 Jul;40(7):538-41. doi: 10.1136/thx.40.7.538.
7
Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.抗革兰氏阴性菌细胞壁糖脂抗体：对菌血症和内毒素血症免疫的诱导
J Infect Dis. 1977 Aug;136 Suppl:S167-73. doi: 10.1093/infdis/136.supplement.s167.
Zotero 插件